PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Org Lett. Author manuscript; available in PMC 2008 December 4.
Published in final edited form as:
PMCID: PMC2593868
NIHMSID: NIHMS60536

An Enantioselective Approach to the Hetisine Alkaloids. Synthesis of the 3-Methyl-1-aza-tricyclo[5.2.1.03,8]decane Core via Intramolecular Dipolar Cycloaddition

Abstract

An efficient, enantioselective approach to the hetisine class of the C20-diterpenoid alkaloids is described. The strategy involves an intramolecular oxidopyridinium dipolar cycloaddition as the key transformation, in which simultaneous formation of the C5-C6 and C10-C20 bonds in the 3-methyl-1-aza-tricyclo[5.2.1.03,8]decane core of the hetisine alkaloids is effected.

The C20-diterpenoid alkaloids isolated from the Aconitum, Delphinium, Consolida, and Spiraea species comprise a diverse family of compounds among which the atisane class of alkaloids (1) is a principal constituent.1 This class of compounds is in turn composed of several structural subclasses of alkaloids, exhibiting varied degrees of structural complexity and pharmacological activity. The hetisine class of alkaloids is among the most structurally complex subgroup of this family and is exemplified by kobusine (2),2 incorporating additional C14-C20 and N-C6 linkages relative to the atisane skeleton.3 Kobusine was among the earliest reported hetisine alkaloids, and it, together with several of its C15-O-acyl derivatives, has recently been shown to exhibit potent vasodilating activity in vivo.4

Although the structure of the hetisine alkaloids have been known for more than 40 years, synthetic investigations into these natural products have been rather sparse due to the formidable challenges in constructing the 3-methyl-1-aza-tricyclo[5.2.1.03,8]decane substructure (3, Scheme 1) embedded within the diterpene-derived carbon scaffold. To this end, a few creative racemic approaches to the construction of bridged aza-bicyclo substructures of the hetisine alkaloids have been reported.5 Model structures of the aza-tricyclo core have also been accessed via late-stage stepwise formation of the C-N bonds on a suitably derivatized polycyclic carbon skeleton,6 with the latter efforts culminating in a recent synthesis of (±)-nominine in a 40-step sequence.7 However, the notable paucity of efficient asymmetric strategies to the aza-tricyclo core 3, characteristic of all hetisine alkaloids, led us to consider the preparation of this substructure via simultaneous formation of the C5-C6 and C10-C20 bonds with the intramolecular combination of an appropriate aza-dipole and dipolarophile (3[implies]4).

Initial investigations into the feasibility of the strategy involved the use of an oxidopyridinium betaine as a relatively stable endocyclic aza-dipole8 tethered to a 2-enenitrile dipolarophile in a dipole-HOMO-controlled cycloaddition (Scheme 2). Preparation of the cycloaddition precursor commenced with 1,4-addition of cyanide to 3-methylcyclohex-2-enone (5) with Et2AlCN. The putative aluminum enolate was then activated in situ with cesium fluoride and subsequently trapped with Tf2O to give the vinyl triflate 6 in 69% yield. Reduction of the nitrile in 6 to the corresponding aldehyde with DIBAL-H (82%) followed by immediate reductive amination with furfurylamine provided furanyl amine 7 (99%). Palladium catalyzed cyanation9 of the enol triflate in 7 proceeded in 75% yield and was followed by Br2-mediated oxidative rearrangement of the furan moiety10 to afford oxidopyridinium ylide 9 in 65%. Heating the oxidopyridinium in a variety of solvents to effect dipolar cycloaddition on the C5-C10 dipolarophile (10) was, however, unsuccessful as direct intramolecular conjugate addition of the oxidopyridinium nucleophile to C5 (11) was the dominant reaction manifold, affording the racemic tricyclic oxidopyridinium betaine 12 (73%).

While the formation of 12 in and of itself constitutes a novel approach to the preparation of highly substituted indolizinium heterocycles,11 the suppression of direct 1,4-addition is critical to the construction of the hetisine azatricyclic core. This led to the consideration of a new cycloaddition substrate in which a removable electron-deficient auxiliary (Z) is introduced at C5 rather than at C10 of the dipolarophile to favor the cycloaddition manifold (13, Scheme 3). The undesired direct conjugate addition pathway with this substrate would involve nucleophilic addition into the C10-position (i.e., 14→15). This process is likely to experience enhanced nonbonding interactions with the necessary positioning of both the C1- and C2-methylene groups directly over the oxidopyridinium ring in the formation of the unwanted bridged aza-bicyclo[3.3.1]nonane oxidopyridinium 15.

To evaluate this hypothesis, preparation of the new cycloaddition precursor 22 proceeded in a sequence that is also readily amenable to asymmetric induction (Scheme 4). Asymmetric α-methylation of 2-oxo-cyclohexanecarboxylic acid ethyl ester (16) via its corresponding (S)-t-butylvaline enamine derivative12 provided the α,α-disubstituted cyclohexanone 17 in 53% (98:2 er). Dehydrative condensation of 17 with thiophenol produced vinyl sulfide 18 in 93% yield to install the π-system of the dipolarophile. Reduction of the ethyl ester within 18 to the alcohol with DIBAL-H (99%) followed by oxidation with IBX afforded the aldehyde 19 in 95% yield. Oxidation of the vinyl sulfide with mCPBA (94%) allowed for the introduction of the dipolarophile activating group at C5 in the form of an aryl sulfone. Reductive amination of aldehyde 20 with furfuryl amine afforded the furanyl amine 21 (91%), which underwent facile oxidative rearrangement with bromine in aqueous acetic acid to produce oxidopyridinium betaine 22 in 77% yield. Heating of 22 in toluene (0.05 mM) at reflux produced the cycloadduct 23 in 70% yield with no evidence of products arising from simple conjugate addition (i.e., 15). Initial structure determination of the cycloadduct 23 came from a battery of NMR data (1H, COSY, HMQC) including an observed nOe between the C4-methyl group and the C6- angular proton, data consistent with a regioselective dipole-HOMO-controlled cycloaddition. Structure verification of the cycloadduct ultimately came from single crystal X-ray analysis. Conjugate reduction of 23 and subsequent triflation of the transient enolate with PhNTf2 13 yielded the corresponding vinyl triflate (70%), which was reduced to the alkene 24 with formic acid and PdCl2(PPh3)2 (84%).14 Finally, desulfurization of the C5-sulfone to form 25 proceeded in 82%, demonstrating that this dipolarophile activating auxiliary can be removed without rearrangement or β-elimination in the newly constructed aza-tricylcic skeleton.

In summary, the first asymmetric synthesis of the 3-methyl-1-aza-tricyclo[5.2.1.03,8]decane core of the hetisine alkaloids is reported. The strategy involves an intramolecular oxidopyridinium dipolar cycloaddition as the key transformation in which simultaneous formation of the C5-C6 and C10-C20 bonds is effected. The facile preparation of (+)-25 clearly demonstrates feasibility of this approach and holds promise for the efficient asymmetric synthesis of the hetisine class of alkaloids.

Figure 1
Atisane and hetisine alkaloids.

Supplementary Material

si20050526_044

Supporting Information Available:

Experimental details and analytical data for synthetic intermediates (PDF). This information is available at http://pubs.acs.org.

Acknowledgment

This research was supported by the NIH (GM67659). A Pharmacia (Pfizer) predoctoral fellowship to KMP is acknowledged.

References

1. Wang F-P, Liang X-T. In: The Alkaloids. Cordell GA, editor. Vol. 59. San Diego, CA: Academic Press; 2002. pp. 1–280. [PubMed]
2. Suginome H, Shimanouti F. Justus Liebigs Ann. Chem. 1940;545:220–228.
3. (a) Okamoto T. Chem. Pharm. Bull. 1959;7:44–49. (b) Pelletier SW, Wright LH, Newton MG, Wright H. J. Chem. Soc., Chem. Commun. 1970:98–99. (c) Sakai S, Yamamoto I, Yamaguchi K, Takayama H, Ito M, Okamoto T. Chem. Pharm. Bull. 1982;30:4579–4584. (d) Ulubelen A, Desai HK, Srivastava SK, Hart BP, Park J, Joshi BS, Pelletier SW, Mericli AH, Mericli F, Ilarslan R. J. Nat. Prod. 1996;59:360–366. [PubMed]
4. (a) Wada K, Ishizuki S, Mori T, Bando H, Murayama M, Kawahara N. Biol. Pharm. Bull. 1997;20:978–982. [PubMed] (b) Wada K, Ishizuki S, Mori T, Fujihira E, Kawahara N. Biol. Pharm. Bull. 1998;21:140–146. [PubMed] (c) Wada K, Ishizuki S, Mori T, Fujihira E, Kawahara N. Biol. Pharm. Bull. 2000;23:607–615. [PubMed]
5. (a) van der Baan JL, Bickelhaupt F. Recl. Trav. Chim. Pays-Bas. 1975;94:109–112. (b) Kwak Y, Winkler JD. J. Am. Chem. Soc. 2001;123:7429–7430. [PubMed] (c) Williams CM, Mander LN. Org. Lett. 2003;5:3499–3502. [PubMed]
6. (a) Shibanuma Y, Okamoto T. Chem. Pharm. Bull. 1985;33:3187–3194. (b) Muratake H, Natsume M. Tetrahedron Lett. 2002;43:2913–2917.
7. Muratake H, Natsume M. Angew. Chem., Int. Ed. 2004;43:4646–4649. [PubMed]
8. (a) Katritzky AR, Takeuchi Y. J. Am. Chem. Soc. 1970;92:4134–4136. (b) Dennis N, Katritzky AR, Takeuchi Y. Angew. Chem., Int. Ed. Engl. 1976;15:1–9. [PubMed] (c) Joshi RA, Ravindranathan T. Ind. J. Chem B. 1984;23:300–302. (d) Katritzky AR, Dennis N. Chem. Rev. 1989;89:827–861. (e) Jung ME, Longmei Z, Tangsheng P, Huiyan Z, Yan L, Jingyu S. J. Org. Chem. 1992;57:3528–3530. (f) Pham VC, Charlton JL. J. Org. Chem. 1995;60:8051–8055. (g) Śliwa W. Heterocycles. 1996;43:2005–2029. (h) Rumbo A, Mouriño A, Castedo L, Mascareñas JL. J. Org. Chem. 1996;61:6114–6120. [PubMed] (i) Smith MP, Johnson KM, Zhang M, Flippen-Anderson JL, Kozikowski AP. J. Am. Chem. Soc. 1998;120:9072–9073.
9. Yamamura K, Murahashi S. Tetrahedron Lett. 1977;18:4429–4430.
10. (a) Müller C, Diehl V, Lichtenthaler FW. Tetrahedron. 1998;54:10703–10712. (b) Ciufolini MA, Hermann CYW, Dong Q, Shimizu T, Swaminathan S, Xi N. Synlett. 1998:105–114.
11. Shono T, Matsumura Y, Tsubata K, Inoue K, Nishida R. Chem. Lett. 1983:21–24.
12. (a) Tomioka K, Ando K, Takemasa Y, Koga K. J. Am. Chem. Soc. 1984;106:2718–2719. (b) Ando K, Takemasa Y, Tomioka K, Koga K. Tetrahedron. 1993;49:1579–1588.
13. Crisp GT, Scott WJ. Synthesis. 1985:335–337.
14. Cacchi S, Morera E, Ortar G. Tetrahedron Lett. 1984;25:4821–4824.